15 results · 22ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

M2A 32MM TAPER SYSTEM

FDA 510(k)
FDA Class 2 ·Orthopedic

PROSTHESIS, HIP

FDA Adverse Event
Injury ·ZIMMER BIOMET, INC.·Product code KWY·November 11, 2021

TruForm

FDA UDI
Rmo, Inc.·00885797099853·MN 2ND BI BD KT N/L UNIV 123

Premier Elevator

FDA UDI
PREMIER DENTAL PRODUCTS COMPANY·00348783004076·ELEVATOR 304 B

Alpha-Tec Systems

FDA UDI
Alpha-TEC Systems, Inc.·00816085022833·SAF Fixative 50 vials

MEDOVATIONS ESOPHAGEAL DILATOR

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

MODIFICATION TO ZEUS SCIENTIFIC, INC., THYROGLOBULIN IGG ELISA TEST SYSTEM

FDA 510(k)
FDA Class 2 ·Immunology

TIBIAL COMPONENT PRECOAT RIGHT MEDIAL/LEFT LATERAL SIZE 3

FDA Adverse Event
Injury ·ZIMMER, INC.·Product code HSX·February 3, 2017

MESH - COMPOSIX KUGEL

FDA Adverse Event
Injury ·DAVOL INC.·Product code FTL·June 14, 2011

DEXTRUS 4136

FDA Adverse Event
Malfunction ·BIOTRONIK SE & CO. KG·Product code NVZ·February 13, 2013

COLLEAGUE COLOR PUMP CE FRENCHVERSION SINGLE

FDA Adverse Event
Malfunction ·BAXTER HEALTHCARE - SINGAPORE·Product code FRN·March 1, 2011

SELUTE PICOTIP

FDA Adverse Event
Death ·CARDIAC PACEMAKERS, INC., GUIDANT PUERTO RICO B.V.·Product code DTB·February 15, 2008

smiths medical PORTEX Tracheal Tube Exchange Guide, 15Ch x 70cm, REF 14-504-68 and REF 14-504-68JP

FDA Enforcement
Class II ·Ongoing·Smiths Medical ASD, Inc.·December 4, 2024

Boston Scientific/Cameron Health SQ-RX Model 1010 subcutaneous pulse generators. The S-ICD System is intended to provide therapy for the treatment of life-threatening ventricular tachyarrhythmias.

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·March 27, 2013

CADD-Solis Ambulatory Infusion Pumps, Model 2100. Intended for the following uses: Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024